瓣膜病终身管理与瓣膜耐久性大师课（CSI @ China Valve 联合论坛）
CSI @ China Valve Lifetime management Valve durability Joint Symposium
04/30 14:00-15:30
主会场 (Main Arena)
主持 : Horst SIEVERT (CardioVascular Center Frankfurt, Germany), 王建安(WANG Jian-An) (浙江大学医学院附属第二医院), Thomas PILGRIM (Bern University Hospital, Switzerland), Eberhard GRUBE (University Hospital Bonn, Germany), Kentaro HAYASHIDA (Keio University School of Medicine, Japan), Andreas RUCK (Karolinska University Hospital, Sweden), Gerald YONG (Fiona Stanley Hospital, Australia), Daisuke HACHINOHE (Sapporo Heart Center, Japan)
讨论嘉宾 : Kentaro HAYASHIDA (Keio University School of Medicine, Japan), Horst SIEVERT (CardioVascular Center Frankfurt, Germany), Andreas RUCK (Karolinska University Hospital, Sweden), Gerald YONG (Fiona Stanley Hospital, Australia), Daisuke HACHINOHE (Sapporo Heart Center, Japan), 何奔(HE Ben) (上海市胸科医院), 宋光远(SONG Guang-Yuan) (首都医科大学附属北京安贞医院), 张龙岩(ZHANG Long-Yan) (武汉亚心总医院), 李妍(LI Yan) (空军军医大学唐都医院)
-
14:00-14:05
-
14:05-14:15长预期寿命患者最佳瓣膜介入治疗实践：年轻、低危和/或二叶瓣患者Optimal Intervention for the Patient with Longer Life Expectancy: Younger, Low Risk and/or Bicuspid
-
14:15-14:21讨论Discussion
-
14:21-14:31如何使用最佳植入技术实现最佳瓣膜性能Optimal Implantation Technique to Achieve Maximum Prosthesis Performance
-
14:31-14:37讨论Discussion
-
14:37-14:47TAVR 后血流动力学和瓣膜持久性：我们什么时候才能得到答案？Post TAVR Hemodynamics and Valve Durability: When Will We Have the Answer
-
14:47-14:53讨论Discussion
-
14:53-15:03TAVR 后的终身管理：瓣膜血栓形成、抗凝及抗血小板Lifetime Management Considerations After TAVR: Valve thrombosis, Anticoagulation or Antiplatelet
-
15:03-15:09讨论Discussion
-
15:09-15:19规划未来：V-in-V 和 V-in-V-in-V器械选择和预后Plan for the Future: V-in-V and V-in-V-in-V THV Selection and Outcome
-
15:19-15:25讨论Discussion
-
15:25-15:40Background on FMR Treatment Options: The Carillon Mitral Contour System
-
15:40-15:45